Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Research brief

Look AHEAD trial reframed through geroscience: lifestyle intervention versus diabetes support and education

The 10-year Look AHEAD trial compared an intensive multidomain lifestyle intervention with a diabetes support and education program for cardiovascular events and other diabetes- and obesity-related outcomes; follow-up continues, and investigators have retrospectively reframed the study from a geroscience perspective. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The 10-year Look AHEAD trial compared a multidomain intensive lifestyle intervention with a diabetes support and education program, with major cardiovascular disease events as the primary outcome. [1]

  2. Follow-up of the cohort continues and adds other aging-related outcomes and conditions to identify long-term consequences of lifestyle- and medical-care-related factors. [1]

  3. Investigators retrospectively reframed the study from a geroscience perspective, which the abstract says strengthens the importance of lifestyle changes to slow biological aging in these individuals. [1]

The source at a glance

Study type / format
Abstract of a 10-year clinical trial with continuing cohort follow-up and retrospective reframing.
Population / context
People with type 2 diabetes and overweight or obesity in the Look AHEAD cohort.
Summary based on
Study abstract
Original publication
January 23, 2026

Look AHEAD compared lifestyle intervention with diabetes support

The 10-year Action for Health in Diabetes (Look AHEAD) clinical trial compared a multidomain intensive lifestyle intervention with a diabetes support and education program. The primary outcome was major cardiovascular disease events; other diabetes- and obesity-related outcomes were also examined. The abstract does not report participant numbers, the specific lifestyle components or the results.

Supporting source [1]

Follow-up adds aging-related outcomes to the cohort

Follow-up of the cohort continues and adds other aging-related outcomes and conditions. The aim is to identify the long-term consequences of factors related to lifestyle and medical care. The abstract does not state how long follow-up has lasted, how many people remain in the cohort or which specific aging-related outcomes are added.

Supporting source [1]

Retrospective geroscience reframing of a diabetes cohort

The investigators retrospectively reframed the study using the perspective of geroscience, as the cohort transitions to a study of aging among people at risk for accelerated aging due to type 2 diabetes and overweight or obesity. According to the abstract, this perspective strengthens the importance of lifestyle changes as a core component of medical care for these individuals to slow biological aging. This is a stated perspective, not a tested result.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. The abstract reports no participant numbers, follow-up duration, intervention details or results, and the geroscience reframing is a stated perspective rather than a tested finding.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
The Look AHEAD Research Program: A 25-Year Retrospective From the Perspective of Geroscience.

Mark A. Espeland, Charles T. Semelka, Stephen B. Kritchevsky, Joni K. Evans, Anne B. Newman · doi.org · January 23, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    compared a multidomain intensive lifestyle intervention to
  2. Finding 2 ↑

    Follow-up of the cohort continues to add
  3. Finding 3 ↑

    retrospectively reframed the study using the perspective

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…